Navigation Links
Delcath Announces Fiscal 2011 Third Quarter Results and Recent Developments
Date:11/7/2011

amp;A) expenses were $5.7 million for the third quarter of 2011, compared to $3.2 million for the same period in the prior year.
The increase in G&A was primarily due to an expansion in staff as the Company continued its progress in transitioning from a development stage company to a commercial enterprise and preparations for commercialization in Europe. Research and development (R&D) expenses were $6.4 million for the third quarter of 2011, compared to $4.3 million for the same period in the prior year.
The increase in R&D expenses was primarily due to our expanded research and development activities and regulatory expenses related to the preparation of our NDA submission for the FDA.

For the nine months ended September 30, 2011, the Company's operating loss was $30.5 million, which included approximately $3.4 million in non-cash stock-based compensation expense. This compares to an operating loss for the nine months ended September 30, 2010 of $21.2 million, which included approximately $3.9 million in non-cash stock-based compensation expense. G&A expenses were $15.1 million for the nine months ended September 30, 2011, compared to $9.4 million for the nine months ended September 30, 2010. The increase in G&A was primarily due to an expansion in staff as the Company continued its progress in transitioning from a development stage company to a commercial enterprise and preparations for commercialization in Europe. R&D expenses were $15.3 million for the nine months ended September 30, 2011, compared to $11.8 million during the first nine months of 2010. During 2010, the Company was incurring expenses related to wrapping up its Phase III clinical trial. The reduction in trial related expenses during 2011 was more than offset by an increase in expenses related to our expanded research and development activities and regulatory expenses related to our submission to the FDA.

At September 30, 2011, cash, cash equivalents and c
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Delcath Systems to Report Third Quarter Progress and Conduct Conference Call
2. FDA Schedules Delcath Pre-New Drug Application Meeting Date
3. Delcath Announces Completion of Regulatory Notification Process in New Zealand
4. Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress
5. Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011
6. Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting
7. Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System
8. Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System
9. Delcath to Present at the Wedbush 2011 Life Sciences Conference on August 16, 2011
10. Delcath Systems to Report Second Quarter Progress Update and Conduct Conference Call
11. Delcath Systems, Inc. Announces the Completion of Common Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... New York , July 31, 2014 ... Global and China Insulin Market (Rapid-Acting, Short-Acting, ... Industry Analysis, Size, Share, Growth, Trends and Forecast (Value ... Forecasts Research Report. Diabetes, growing at an ... The disease has emerged as a major cause of ...
(Date:7/30/2014)...  Hologic, Inc. (NASDAQ: HOLX ) today ... June 28, 2014. Third Quarter Financial Highlights ... $632.6 million, reflecting operational growth of 0.5% and a ... period in the prior year. , Revenues grew ... Health revenues grew 3.5%. , GYN Surgical revenues ...
(Date:7/30/2014)... July 30, 2014  Unilife Corporation ("Unilife" or ... developer and supplier of injectable drug delivery systems, ... capacity, R&D, and facilities in response to increasing ... products and services. During the fourth quarter of ... million in capital expenditures and R&D above normal ...
Breaking Medicine Technology:The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 2The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 3The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 4The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 5The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 6The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 7The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019 8Hologic Announces Third Quarter Fiscal 2014 Operating Results 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 3Hologic Announces Third Quarter Fiscal 2014 Operating Results 4Hologic Announces Third Quarter Fiscal 2014 Operating Results 5Hologic Announces Third Quarter Fiscal 2014 Operating Results 6Hologic Announces Third Quarter Fiscal 2014 Operating Results 7Hologic Announces Third Quarter Fiscal 2014 Operating Results 8Hologic Announces Third Quarter Fiscal 2014 Operating Results 9Hologic Announces Third Quarter Fiscal 2014 Operating Results 10Hologic Announces Third Quarter Fiscal 2014 Operating Results 11Hologic Announces Third Quarter Fiscal 2014 Operating Results 12Hologic Announces Third Quarter Fiscal 2014 Operating Results 13Hologic Announces Third Quarter Fiscal 2014 Operating Results 14Hologic Announces Third Quarter Fiscal 2014 Operating Results 15Hologic Announces Third Quarter Fiscal 2014 Operating Results 16Hologic Announces Third Quarter Fiscal 2014 Operating Results 17Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 2Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 3Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 4Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 5
... Pharmaceuticals, a division of Wyeth (NYSE: ... ongoing studies, one evaluating neratinib (HKI-272) in combination ... positive) breast cancer, and a separate study investigating ... (Taxol(R), Bristol-Myers Squibb) in patients with HER-2 dependent ...
... Conference Call at 9:00 AM ET Today CORAL ... (Nasdaq: CPRX ) today announced top-line results ... cocaine addiction. The data from the trial showed ... primary endpoint -- that a significantly larger proportion of ...
Cached Medicine Technology:New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 2New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 3New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 4New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 5Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction 2Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction 3Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction 4
(Date:7/31/2014)... With a busy lifestyle, it is hard to ... healthy lifestyle but to ensure their mental health is equally in ... health. “Eating right is key to your body’s health. However, I ... a completely healthy lifestyle,” expressed Chef Ravi, owner of World Gardens ... here . , ", 1. Stop eating lunch at your desk ...
(Date:7/31/2014)... CITY, Mo. (PRWEB) July 31, 2014 ... of highly experienced, sub-specialty trained neurosurgeons at the ... of the Spine Program and director of spine surgery. ... in Richland, Wash. , “Dr. Upadhyaya has been recognized ... invasive and complex spine issues. His addition to the ...
(Date:7/31/2014)... Hills, CA (PRWEB) July 31, 2014 According ... George W. Bush recently underwent partial knee replacement surgery on ... knee less than two months earlier. The story also reports ... the procedures and hopes to be back on the bike ... surgery highlights the benefits of partial knee replacement. , ...
(Date:7/31/2014)... WA (PRWEB) July 31, 2014 ... family practice provider? Community Health Center of Snohomish ... “ Pediatricians vs. Family Doctors ”. Many adults ... are available to them. Community Health Center hopes ... similarities and differences between the two. , ...
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 Recognizing ... International Plant-based Nutrition Healthcare Conference announced today ... enrolled in studies of medicine or a healthcare-related field, ... advantage of special student-only discounts for the conference, scheduled ... the Loews Coronado Bay Resort. , “As ...
Breaking Medicine News(10 mins):Health News:World Garden’s Cafe Launches ‘16 Simple Ways to Feel Connected to the World’ 2Health News:World Garden’s Cafe Launches ‘16 Simple Ways to Feel Connected to the World’ 3Health News:World Garden’s Cafe Launches ‘16 Simple Ways to Feel Connected to the World’ 4Health News:Saint Luke’s Marion Bloch Neuroscience Institute welcomes Cheerag D. Upadhyaya, M.D., as director of Spine Program 2Health News:Saint Luke’s Marion Bloch Neuroscience Institute welcomes Cheerag D. Upadhyaya, M.D., as director of Spine Program 3Health News:Saint Luke’s Marion Bloch Neuroscience Institute welcomes Cheerag D. Upadhyaya, M.D., as director of Spine Program 4Health News:George W. Bush’s Surgery Highlights the Benefits of Partial Knee Replacement 2Health News:Community Health Center of Snohomish County Reveals the Differences Between Pediatricians and Family Practice Providers 2Health News:Student Discounts Offered for International Plant-based Nutrition Healthcare Conference 2Health News:Student Discounts Offered for International Plant-based Nutrition Healthcare Conference 3
... CITY, Calif., Sept. 30 Genomic Health, Inc. ... Health,s Chief Operating Officer and Chief Financial Officer, will present ... City, on Tuesday, October 6 at 9:30 a.m. ET. ... the presentation, visit the Investor Relations section of Genomic Health,s ...
... October is National Breast Cancer Awareness Month and Topcor is ... , Available October 5th, "Clipa for a Cure" is a ... Topcor will donate 10% of the retail price of every ... American Cancer Society, breast cancer is the second leading cause ...
... ... that they now help physicians find jobs on Twitter by using the popular social ... providers. , ... CO (PRWEB) September 29, 2009 -- Onyx M.D., a Denver, Colorado-based physician recruiting company, ...
... ... live. Everyone, including doctors, administrators, nurses, et al, are encouraged to go online to ... ... first multi-disciplinary, online healthcare community. It is designed for everyone in the medical field ...
... The American Federation of Government Employees expresses grave concern at the ... would be rising by an average of 8.8% in 2010. ... for 60% of the enrollees in FEHBP, those covered by Blue ... by 15% for self coverage and 12% for family coverage. ...
... PARSIPPANY, N.J., Sept. 30 Thousands of bacteria lurk ... hygiene routines to help protect themselves from serious illness, ... College Center for Hygiene and Health in Home and ... products.(1) Despite growing concerns about influenza A (H1N1) on ...
Cached Medicine News:Health News:'Clipa for a Cure': New Pink Instant Handbag Hanger Benefits Breast Cancer Research 2Health News:Onyx M.D. Now Tweet Jobs for Physician Job Opportunities by Specialty 2Health News:Onyx M.D. Now Tweet Jobs for Physician Job Opportunities by Specialty 3Health News:Online Healthcare Community, TogetherMD, is Live 2Health News:Study Shows College Students Are Not Following CDC Recommendations to Help Protect Themselves from H1N1 and Other Threatening Germs 2Health News:Study Shows College Students Are Not Following CDC Recommendations to Help Protect Themselves from H1N1 and Other Threatening Germs 3Health News:Study Shows College Students Are Not Following CDC Recommendations to Help Protect Themselves from H1N1 and Other Threatening Germs 4Health News:Study Shows College Students Are Not Following CDC Recommendations to Help Protect Themselves from H1N1 and Other Threatening Germs 5
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: